Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective
- Resource Type
- Article
- Source
- Bone Marrow Transplantation; April 2024, Vol. 59 Issue: 4 p572-574, 3p
- Subject
- Language
- ISSN
- 02683369; 14765365